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Background: Ischemic or volatile anesthetic preconditioning is defined as tissue protection from impending
ischemic cell damage by repetitive short periods of tissue exposure to ischemia or volatile anesthetics. Objective of
this study was to elucidate, if ischemic preconditioning and pharmacological preconditioning with sevoflurane have
effects on muscle tissue oxygen saturation in patients undergoing surgical revascularization of the lower limb.
Methods: In this prospective randomized pilot study ischemic and pharmacological (sevoflurane) preconditioning
was performed in 40 patients with lower limb arterial occlusive disease undergoing surgical revascularization.
Sevoflurane preconditioning was performed in one group (N = 20) by repetitive application of sevoflurane for six
minutes interspersed by six minutes of washout. Thereafter, ischemic preconditioning was performed in all patients
(N = 40) by repetitive clamping of the femoral artery for six minutes interspersed by six minutes of reperfusion.
The effect of both procedures on leg muscle tissue oxygen saturation (rSO2) was measured by near-infrared
spectroscopy during both procedures and during surgery and reperfusion (INVOS® 5100C Oxymeter with Small
Adult SomaSensor® SAFB-SM, Somanetics, Troy, Michigan, USA).
Results: Repetitive clamping and reperfusion of the femoral artery resulted in significant cyclic decrease and
increase of muscle rSO2 (p < 0.0001). Pharmacological preconditioning with sevoflurane resulted in a faster and
higher increase of rSO2 during postoperative reperfusion (Maximal 111% baseline ± 20 versus 103% baseline ± 14,
p = 0.008) consistent with an additional effect of pharmacological preconditioning on leg perfusion.
Conclusions: Ischemic preconditioning of lower limb muscle tissue and pharmacological preconditioning with
sevoflurane have an effect on tissue oxygenation in patients with lower limb occlusive arterial disease.
Trial registration: The trial has been registrated at www.ClinicalTrial.gov, Trial Number: NCT02038062 at 14 January 2014.
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Surgical revascularization of lower limb peripheral occlu-
sive arterial disease is performed, if non-surgical proce-
dures are not sufficient to treat lower limb ischemia [1].
Surgery for peripheral arterial disease of the leg is usually
performed after clamping the femoral artery, thereby* Correspondence: axel.fudickar@uksh.de
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damage. Reperfusion injury may also affect heart, lung
and other organs remote from the ischemic tissue by re-
lease of ischemic metabolites during reperfusion.
Ischemic preconditioning (IPC) is defined as protec-
tion from ischemic cell damage by preceding repetitive
short periods of ischemia followed by reperfusion [2].
IPC may also be achieved by repetitive ischemia of an
organ or limb remote from the protected tissue (Remote
ischemic preconditioning, RIPC) [3].l Ltd. This is an Open Access article distributed under the terms of the Creative
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can decrease myocardial infarct size and improve left
ventricular function by increasing coronary collateral
vessel density and blood flow probably by RIPC [4].
Hence, IPC by repetitive clamping of the femoral artery
before surgery may protect lower limb tissue from ische-
mic and reperfusion injury during and after clamping of
the femoral artery for vascular surgery and may also
protect remote organs as the heart by RIPC. However,
patients with limb ischemia due to occlusive arterial dis-
ease develop collateral vessels to the femoral artery. Due
to the great variability of these vessels bypassing the
femoral artery, it remains unclear if effective ischemia
and reperfusion cycles can be achieved by clamping the
femoral artery [5].
Preconditioning by sevoflurane is a pharmacological
alternative to IPC. Patients who received sevoflurane for
anesthesia during cardiac surgery had decreased postop-
erative mortality, less myocardial infarction and shorter
length of hospital stay [6,7].
Near infrared spectroscopy (NIRS) enables non-invasive
continuous measurement of tissue oxygation. NIRS is pre-
dominantly used for monitoring brain tissue oxygen satur-
ation during cardiac surgery and a decrease by more than
20% from baseline is regarded as critical [8,9]. NIRS has
also been used to measure rSO2 in the lower limb and to
show the correlation of age and tissue perfusion in the an-
terior tibial muscle with sufficient sensitivity to perfusion
changes [10]. NIRS showed also good reproducibility dur-
ing ischemia and reperfusion of the forearm [11] and has
been claimed to be useful for the non-invasive measure-
ment of limb perfusion [12,13]. NIRS has been used to
measure changes in regional tissue oxygen saturation
(rSO2) in the calf muscle of patients with intermittent
claudication during treadmill tests [14]. In another study
the effect of medication on tissue perfusion in patients
with occlusive arterial disease could be demonstrated by
NIRS [15].
Hence, NIRS is regarded as an appropriate method to
measure the effect of IPC and sevoflurane precondition-
ing on lower limb tissue oxygenation.
First purpose of this trial was to investigate, if repeti-
tive clamping of the femoral artery results in repetitive
decrease of leg tissue rSO2. Repetitive decrease of leg tis-
sue rSO2 was regarded as a prerequisite of effective is-
chemic preconditioning of the lower limb in patients
with occlusive arterial disease. Hence, we used NIRS to
investigate the primary hypothesis that repetitive clamp-
ing of the femoral artery results in effective ischemic
preconditioning of the lower limb in patients with occlu-
sive arterial disease. Effective ischemic preconditioning
was defined as two cycles of a statistically and clinically
significant decrease and increase of tissue oxygen satur-
ation measured by NIRS.Second purpose of the trial was to examine, if sevo-
flurane preconditioning of the lower limb would prob-
ably be effective in patients with occlusive arterial
disease. Effective sevoflurane preconditioning was de-
fined as a significant effect of sevoflurane precondition-
ing on rSO2 measured by NIRS during IPC and on rSO2
measured by NIRS during postoperative reperfusion.
Repetitive decrease of leg rSO2 during repetitive
clamping of the femoral artery and measurable effects of
sevoflurane preconditioning on leg rSO2 would justify
the design of a large randomized study to investigate the




Ethics committee approval was obtained by the Ethics
Committee of the University Hospital Schleswig-
Holstein, Campus Kiel, Schwanenweg 20, 24105 Kiel,
Germany. Written informed consent was obtained from
all patients. Between May 2010 and January 2012 40
adult patients undergoing elective surgical treatment of
peripheral occlusive arterial disease with clamping of the
femoral artery under general anesthesia at the University
Hospital Schleswig-Holstein, Campus Kiel were enrolled
in this prospective randomized controlled interventional
pilot study. Randomization was performed by putting 40
cards (20 cards each were labelled with the respective
group assignment) in envelopes, mixing the envelopes
randomly and numbering them consecutively.
Patients with skin disease rendering NIRS impossible
and patients with amputation of the leg opposite to the
side of surgery were excluded from the study.
Induction of anesthesia and surgery
All patients received midazolam (7.5 mg, Hoffmann-La
Roche, Basel, Switzerland) orally 30 minutes preopera-
tively for anxiolysis and sedation. Upon arrival in the
anesthesia induction room, ECG, pulse oximetry and non-
invasive blood pressure were monitored continuously.
Measurement of rSO2 was performed continuously
from arrival at the anesthesia induction room until 20 mi-
nutes after postoperative declamping of the femoral artery
using an INVOS® 5100C Oxymeter (Somanetics, Troy,
Michigan, USA). The optodes (Small Adult SomaSensor®
SAFB-SM, Somanetics, Troy, Michigan, USA) were fixed
above the anterior tibial muscle at both lower legs 20 cm
above the ankle after cleaning the skin with 70% ethanol.
rSO2 of both legs was measured to exclude an oxygen sat-
uration decrease or increase due to a systemic effect on
leg tissue oxygen saturation during clamping.
The anesthetist performing anesthesia was blinded to the
measurement of rSO2. Peripheral venous blood samples
were obtained from the cubital vein for the measurement
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pO2, pCO2 and base excess immediately before induction
of anesthesia.
Anesthesia was induced with intravenous propofol (2 mg.
kg−1, Diprivan®, AstraZeneca, London, GB) and a continu-
ous infusion of remifentanil (0.3 μg.kg−1.min−1, Ultiva®,
GlaxoSmithKline, Brentford, GB). Muscle relaxation was
achieved with rocuronium (0.6 mg.kg−1, Esmeron®, Essex
Pharma, Oss, The Netherlands). After endotracheal intub-
ation, ventilation was adjusted to maintain normocapnia
(FiO2 = 0.3). Anesthesia was maintained with propofol
(4–6 mg.kg−1.h−1) and remifentanil (0.2 - 0.3 μg.kg−1.
min−1). Body temperature was kept normal by use of a
heating blanket (36.5° - 37.5°C). All patients received
cefuroxime (1.5 g) for antibiotic prophylaxis.
As soon as steady state anesthesia was achieved, sevo-
flurane preconditioning was performed in the sevoflur-
ane group (N = 20) by two periods of sevoflurane
application (each lasting 6 minutes) interspersed by 6 mi-
nutes washout on the basis of a previously published
protocol for interrupted administration of sevoflurane
for myocardial preconditioning [16].
Sevoflurane was administered with high fresh gas
flow (10 l.min−1, FiO2 = 0.3). After an endtidal concen-
tration of 1.0 MAC was reached, fresh gas flow was re-
duced to 4 l.min−1. rSO2 was noted immediately before
application of sevoflurane and 1, 3 and 5 minutes there-
after. One minute after the last noted rSO2, the propo-
fol infusion was resumed and sevoflurane was washed
out by discontinuation of sevoflurane and increasing
the fresh gas flow to 10 l.min−1 to achieve a MAC value
below 0.2. rSO2 was noted immediately before washout
and 1, 3 and 5 minutes thereafter. One minute after the
last noted rSO2 during washout, application of sevoflur-
ane and washout were repeated once. Akrinor® (0.5 ml
cafedrine hydrochloride (100 mg.ml−1)/theodrenaline
hydrochloride (10 mg.ml−1)) was given intravenously, if
the systolic blood pressure decreased below 80% of
baseline. In the other patients (IPC only, n = 20), rSO2
was measured during a respective time-matched period
without sevoflurane preconditioning. These patients
were anesthetized for the same period of time as the
sevoflurane group.
After final washout of sevoflurane, IPC was performed
in both groups by clamping the femoral artery at the
side of surgery for 6 minutes. Clamping was performed
using the same clamp (Pilling® Cooley Anastomosis
Clamp, Teleflex® Medical, New York, USA) and the same
clamping technique, as for definite clamping for surgery.
rSO2 was noted immediately before clamping and 1, 3
and 5 minutes thereafter. One minute after the last
noted rSO2 during clamping, the reperfusion period was
started by declamping. rSO2 was noted immediately be-
fore declamping and 1, 3 and 5 minutes thereafter. Oneminute after the last rSO2 during reperfusion, clamping
and reperfusion were repeated once.
Before the first clamping, intravenous heparin (100 units.kg−1,
Heparin-Natrium-5000-Ratiopharm®, Ratiopharm, Ulm,
Germany) was given to all patients. After the second re-
perfusion period, the femoral artery was definitely clamped
for surgery. rSO2 was noted immediately after clamping
for surgery, every 15 minutes during surgery, at declamp-
ing and subsequently at 3, 5, 10 and 20 minutes. After
declamping, the heparin effect was partially reversed by
intravenous protamine (60 – 80% of the initial heparin
dose, MEDA Pharma, Bad Homburg, Germany). Immedi-
ately after extubation, venous blood samples were ob-
tained from the cubital vein for the measurement of
postoperative hemoglobine, hematocrit, lactate, glucose,
potassium, pO2, pCO2 and base excess.
Statistical analysis
Data analysis was performed with commercially available
software (Graph Pad Prism® for Mac, version 5.03, Graph-
Pad Software, San Francisco, USA).
The data were tested for normality using the Kolmogorov-
Smirnov test. The influence of time and an additional fac-
tor (the side (left or right) or the medical preconditioning
(with or without sevoflurane)) was analyzed by an ANOVA
with repeated measurements with time as within subjects
factor and side or medical preconditioning as between
subjects factor.
The results were corrected for multiple testing. Para-
metric data are given as mean ± standard deviation. Dif-
ferences between two groups were analyzed by the t-test
for parametric data. P < 0.05 was considered statistically
significant. Incidences of diagnoses, medications and lo-
calizations of stenoses were compared with Fisher’s exact
test. Differences between laboratory values obtained be-
fore and after surgery and correlations of age, hemoglo-
bine, ankle brachial index, sex, hyperlipidemia, diabetes
mellitus and statins with rSO2 were investigated explor-
atively without correction for multiple testing.
If a medium effect size of f = 0.25, a medium correl-
ation of 0.5 among repeated measures and a nonspheri-
city correction of 1 is assumed, the following power
estimates apply for a significance level of 0.05 (calculated
by G*Power 3.1.6): For all four time periods (sevoflurane
preconditioning, ischemic preconditioning, clamping
for surgery and postoperative reperfusion) the power for
detecting a time effect was >99% and the power for
detecting a side effect was about 85%. The power for de-
tecting a medication effect varied between 38% (clamp-
ing for surgery), 54% (postoperative reperfusion) and
56% (sevoflurane preconditioning and ischemic precon-
ditioning). The power for detecting an interaction be-
tween time and side or medication effect was for all
time periods >99%.






IPC (N = 20)
Angiotensin converting enzyme inhibitor 9 (45%) 14 (70%)
Acetylsalicylic acid 16 (80%) 14 (70%)
Angiotensine 1 antagonist 4 (20%) 1 (5%)
β-adrenergic inhibitor 13 (65%) 13 (65%)
Calcium channel blocking agents 8 (40%) 5 (25%)
Diuretics 9 (45%) 4 (20%)
Digitalis 0 (0%) 3 (15%)
Insulin 5 (15%) 1 (5%)
Oral antidiabetics 2 (10%) 4 (20%)
Statins 8 (40%) 10 (50%)
Platelet aggregation inhibitor 2 (10%) 2 (10%)
Superficial femoral artery 14 (70%) 13 (65%)
Common femoral artery 12 (60%) 9 (45%)
External iliac artery 7 (35%) 6 (30%)
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Demographic data and characteristics of patients
Demographic data and diagnoses are presented in Table 1.
Most patients (n = 28) had peripheral occlusive arterial
disease with Fontaine grade IIb. Medications and localiza-
tions of stenoses leading to surgery are shown in Table 2.
Most frequent localizations were the superficial femoral
artery (n = 27), the common femoral artery (n = 21) and
the external iliac artery (n = 13).
Perioperative tissue oxygen saturation (rSO2)
Baseline rSO2
Mean baseline rSO2 of all patients was 64% ± 11 on the
side of surgery and 65% ± 11 on the opposite side (Differ-
ence not significant). There was no significant difference of
mean baseline rSO2 between patients with sevoflurane pre-
conditioning and the control group (66% ± 12 vs. 62% ±
10). After induction of anesthesia, mean rSO2 of all pa-
tients was 66% ± 12 at the side of surgery and 66% ± 11 at






IPC (N = 20)
Age (years) 68 ± 12 68 ± 11
Height (cm) 170 ± 11 170 ± 8




27 ± 5 26 ± 3
Ankle-Brachial-Index (ABI)* 0.58 ± 0.18 0.56 ± 0.05







Obesity 5 (25%) 1 (5%)
Alcohol abuse 1 (5%) 1 (5%)
History of stroke 4 (20%) 1 (5%)
Diabetes mellitus 6 (30%) 5 (25%)
Hyperlipidaemia 14 (70%) 12 (60%)
Hypertonia 18 (90%) 17 (85%)
Hyperuricaemia 1 (5%) 5 (25%)
Coronary heart disease 9 (45%) 6 (30%)
Renal insufficiency 4 (20%) 1 (5%)
Smoking 9 (45%) 10 (50%)
*The “Ankle Brachial Index (ABI)” is defined as the systolic blood pressure
measured at the ankle divided by the systolic blood pressure measured at the
arm [17].
Demographic data, diagnoses and characteristics of patients. Data are given as
mean ± standard deviation or absolute numbers (Percent). Differences
between groups are not significant (“IPC + sevoflurane” = patients with
sevoflurane preconditioning before ischemic preconditioning (IPC), “IPC” = patients
without sevoflurane preconditioning before ischemic preconditioning).
Common iliac artery 4 (20%) 5 (25%)
Profunda femoral artery 2 (10%) 2 (10%)
Internal iliac artery 1 (5%) 0 (0%)
Medications of patients and localization of stenoses in 40 patients undergoing
surgical revascularization of the lower limb due to peripheral occlusive arterial
disease. Data are given as absolute numbers (percent). Differences between
groups are not significant. Total number of localisations is greater than 40,
because there was more than one stenosis in some patients. (“IPC +
sevoflurane” = patients with sevoflurane preconditioning before ischemic
preconditioning (IPC), “IPC” = patients without sevoflurane preconditioning
before ischemic preconditioning).Sevoflurane preconditioning
Figure 1 shows rSO2 in patients during sevoflurane pre-
conditioning (n = 20) and in the group with IPK only dur-
ing the corresponding time interval of surgery (n = 20).
There was no significant effect of the factors “time”
(p = 0.73), “sevoflurane” (p = 0.54) and the combination
of the factors (p = 0.67) on rSO2 during sevoflurane pre-
conditioning (Table 3). There was no significant differ-
ence between the time course of rSO2, on the side of
surgery and the opposite side (control, no IPK) during
sevoflurane preconditioning (p = 0.37, Table 4). Blood
pressure and heart rate remained unchanged during
sevoflurane preconditioning.
Ischemic preconditioning
A significant effect of clamping and declamping during IPC
on rSO2 was observed and the change in rSO2 over time is
different for patients with and without sevoflurane. Figure 2
shows rSO2 in the anterior tibial muscle during ischemic
preconditioning in patients with sevoflurane precondition-
ing (n = 20) and patients with IPC only (n = 20). There was
a significant effect of the factor “time” (time from beginning
Figure 1 rSO2 in the anterior tibial muscle during sevoflurane preconditioning and in a time-matched interval. rSO2 in the anterior tibial
muscle of patients during sevoflurane preconditioning (IPC + Sevoflurane, n = 20) and rSO2 of patients without sevoflurane preconditioning (IPC,
n = 20) during a corresponding time-matched interval between induction of anesthesia and ischemic preconditioning. There was no significant
difference between the groups. rSO2 has been normalized to baseline prior to induction of anesthesia to facilitate group comparison.
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the combination of the factors “time” and “sevoflurane”
(patients with sevoflurane preconditioning vs. patients
without sevoflurane preconditioning, p = < 0.0001) on rSO2
(Table 3). In patients with sevoflurane preconditioning
rSO2 decreased less during the first clamping and more
during the second clamping than in patients with IPC only.
There was also a significant difference between the time
course of rSO2 measured at the leg at which surgery was
performed and rSO2 measured on the opposite leg (control,
no surgery and no IPC) during IPC (p = 0.0007, Table 4).
rSO2 decreased on the side with IPC, but not on the other
side, thus indicating achievement of significant ischemia in
comparison to the leg opposite to the side of surgery during
IPC by clamping of the femoral artery. Mean rSO2 of all pa-
tients immediately before ischemic preconditioning was
64% ± 12. Mean rSO2 of the sevoflurane group was 66% ±
13 and mean rSO2 of the control group was 62% ± 11 (Dif-
ference of means not significant). The time course of rSO2,
however, showed not in all patients a significant decrease
and increase (defined as more than twofold the precision ofTable 3 Effects of time and sevoflurane preconditioning on lo





Interaction of “Time”with “Sevoflurane” 0.67
Effects of the factors “time” and “sevoflurane preconditioning (sevoflurane)” and the in
ischemic preconditioning, clamping for surgery or postoperative reperfusion) with
on tissue oxygen saturation during sevoflurane preconditioning, ischemic precondition
measurements with side as inter subject factor). Tissue oxygen saturation was mea
effects are marked with asterisks (*).the measurement) as exspected during clamping and reper-
fusion. A significant decrease during each of both clamping
periods and increase during both reperfusion periods by
more than twofold the precision of the measurement was
observed in 22 patients (11 in the sevoflurane group and 11
in the propofol group).
Clamping of the femoral artery for surgery
Blood flow due to collateral vessels was present in the
clamped artery in all patients. During clamping of the
femoral artery for surgery a significant decrease of rSO2
was observed in both groups. Figure 3 shows rSO2 in
the anterior tibial muscle during clamping of the femoral
artery for surgery in patients with sevoflurane precondi-
tioning and controls. Immediately before clamping,
mean rSO2 of the sevoflurane group was 66% ± 13 and
mean rSO2 of the control group was 61% ± 11 (Differ-
ence of means not significant).
There was a significant effect of the factor “time” (p <
0.0001) on rSO2, but no significant effect of the factor
“sevoflurane” (p = 0.34) and the combination of the factorswer limb tissue oxygenation during sevoflurane







< 0.0001* < 0.0001* < 0.0001*
0.95 0.34 0.7
< 0.0001* 0.68 0.008*
teraction of “Time” (time from the beginning of sevoflurane preconditioning,
“sevoflurane” (sevoflurane preconditioning before ischemic preconditioning)
ing, clamping for surgery and postoperative reperfusion (ANOVA with repeated
sured with near-infrared spectroscopy in the anterior tibial muscle. Significant
Table 4 Effect of time and side of measurement (side of surgery versus opposite side) on lower limb tissue oxygen
saturation during sevoflurane preconditioning, ischemic preconditioning, clamping for surgery and postoperative
reperfusion
Sevoflurane preconditioning Ischemic preconditioning Clamping for surgery Postoperative reperfusion
Time 0.61 < 0.0001* < 0.0001* < 0.0001*
Side 0.37 0.0007* 0.0001* 0.0027*
Interaction of “Side”with “Time” 0.74 < 0.0001* < 0.0001* < 0.0001*
Effects of the factors “time” (time from the beginning of sevoflurane preconditioning, ischemic preconditioning, clamping for surgery or psotoperative
reperfusion) and “side” (side of surgery versus opposite side) on lower limb tissue oxygen saturation during sevoflurane preconditioning, ischemic
preconditioning, clamping for surgery and postoperative reperfusion (ANOVA with repeated measurements with side as inter subject factor). Tissue oxygenation
was measured with near-infrared spectroscopy in the anterior tibial muscle. Significant effects are marked with asterisks (*).
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Time course of rSO2 on the side of surgery and on the op-
posite side (control, without IPC) were significantly differ-
ent during clamping of the femoral artery (p = 0.0001,
Table 4).
Reperfusion after declamping
A significantly faster increase of rSO2 was observed in
the sevoflurane group in comparison to the group with
IPC only during reperfusion after declamping. Figure 4
shows rSO2 in the anterior tibial muscle during reperfu-
sion after declamping of the femoral artery in patients
with sevoflurane preconditioning and controls. Mean
rSO2 immediately before declamping was 48% ± 16 in
the sevoflurane group and 54% ± 16 in the group with
IPC only (Difference of means not significant, p = 0.99).
There was a significant effect of the factor “time” (p <
0.0001) and the combination of the factors “time” and
“sevoflurane” (p = 0.008) on rSO2 during reperfusion
(Table 3). Time course of rSO2 on the side of surgery and
on the opposite side (control, without IPC) was significantlyFigure 2 rSO2 in the anterior tibial muscle during ischemic precondit
with (IPC + Sevoflurane, n = 20) and without (IPC, n = 20) sevoflurane precond
the factor “time” (p < 0.0001) and the combination of the factors “time” and “s
to induction of anesthesia to facilitate group comparison.different after declamping of the femoral artery (p =0.0027,
Table 4).
Laboratory values
Table 5 shows serum hemoglobine, hematocrit, lactate,
glucose, potassium, pO2, pCO2 and base excess in the
peripheral venous blood of patients with sevoflurane
preconditioning and controls. There was no difference
of baseline values before surgery between the groups
and no difference of changes in relation to baseline after
surgery between the groups.
Heart rate and mean arterial pressure during
preconditioning, surgery and reperfusion
There was no difference between the heart rates of the
sevoflurane and control groups. A difference between
mean arterial pressure between the sevoflurane group and
controls was observed during the first wash-in of sevoflur-
ane preconditioning only. Mean arterial pressure was 79
± 23 mmHg in the sevoflurane group and 96 ± 23 mmHg
in the control group one minute after the beginning ofioning. rSO2 in the anterior tibial muscle during ischemic preconditioning
itioning before ischemic preconditioning. There was a significant effect of
evoflurane” (p = < 0.0001) on rSO2. rSO2 was normalized to baseline prior
Figure 3 rSO2 in the anterior tibial muscle during clamping of the femoral artery for surgery. rSO2 in the anterior tibial muscle during
clamping of the femoral artery for surgery with (IPC + sevoflurane) and without (IPC) sevoflurane preconditioning before ischemic preconditioning
(IPC). There was a significant effect of the factor “time” on rSO2 (p < 0.0001), but no significant difference between the groups. rSO2 was normalized to
baseline prior to induction of anesthesia to facilitate group comparison.
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remained largely unchanged until the first wash-out. From
the beginning of first wash-out no difference of mean ar-
terial pressure was observed between groups.
Clinical outcome data
We did not observe any difference between the groups
regarding postoperative length of hospital stay, major
cardiac events, and length of follow up period. Length of
hospital stay was 5 (3–9) days in the sevoflurane group
and 5 (3–16) days in the group with IPK only (median
(range)). Myocardial infarctation occurred in one patient
in each group. No fatal outcome was found in the followFigure 4 rSO2 in the anterior tibial muscle after declamping of the fe
the femoral artery in patients with sevoflurane preconditioning (IPC + sevo
before ischemic preconditioning (IPC). rSO2 was normalized to baseline priup charts. However, there was a wide variety of follow
up periods. Longest available follow up period was 1,5
(1–4) years in the sevoflurane group and 1 (0–4) years
in the group with IPK only (median (range)). Thus, a
fatal outcome shortly after discharge could not be ex-
cluded in some cases.
Discussion
Main results of our prospective randomized interven-
tional pilot study are:
1. Repetitive clamping of the femoral artery for IPC
induced a significant repetitive decrease of mean legmoral artery. rSO2 in the anterior tibial muscle after declamping of
flurane, n = 20) and without sevoflurane preconditioning (IPC, n = 20)
or to induction of anesthesia to facilitate group comparison.
Table 5 Laboratory values
IPC + sevoflurane IPC
(N = 20) (N = 20)
Laboratory value Baseline Post OP p-value Baseline Post OP p-value
Hemoglobine (mg*dl−1) 13.9 ± 2.2 11.5 ± 2.2 < 0.0001 13.8 ± 1.8 11.2 ± 1.4 < 0.0001
Hematokrit (%) 42.6 ± 6.8 34.5 ± 5.7 < 0.0001 42.2 ± 5 34 ± 4 < 0.0001
Lactate (mmol*l−1) 1.0 ± 0.3 0.8 ± 0.26 0.07 1 ± 0.3 0.8 ± 0.23 0.008
Glucose (mg*dl−1) 118 ± 44.7 104.7 ± 36.2 0.005 113.3 ± 34.6 105.2 ± 25 0.17
Potassium (mmol*l−1) 4.2 ± 0.8 4.3 ± 0.7 0.05 3.9 ± 0.4 4.1 ± 0.3 0.02
Base excess (mmol*l−1) 0.38 ± 2.01 0.24 ± 2.48 0.71 0.56 ± 1.88 0.02 ± 2.02 0.19
Serum laboratory values of patients undergoing surgical revascularization of occlusive arterial disease with sevoflurane preconditioning before ischemic
preconditioning and patients with ischemic preconditioning only (“IPC + sevoflurane” = patients with sevoflurane preconditioning before ischemic preconditioning
(IPC), “IPC” = patients without sevoflurane preconditioning before ischemic preconditioning). Differences between patients with sevoflurane preconditioning
before IPC and patients with IPC only are not significant (Baseline = preoperative blood sample, Post OP = postoperative blood sample, p-values exploratively
without correction for multiple testing).
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sevoflurane preconditioning.
2. During IPC, a decrease of leg muscle rSO2 during
each clamping of the femoral artery and a
comparable increase of leg muscle rSO2 during each
reperfusion was observed in 22 of 40 patients.
3. Sevoflurane preconditioning had a significant effect
on the time course of leg muscle rSO2 during
ischemia and reperfusion both during IPC and
during postoperative reperfusion.
Peripheral occlusive arterial disease of the lower limb is a
frequent disease with an increased risk of death explained
by the association with coronary heart disease and cere-
bral vascular disease. Surgical revascularization by end-
arterectomy is recommended in approximately 10% of all
patients, but amputation can not be avoided in 6.6% of pa-
tients and perioperative mortality is 1% [18-20]. Hence, it
seemed reasonable to investigate IPC and sevoflurane pre-
conditioning as potential tools to improve outcome after
surgical revascularization.
Mean age and gender distribution of the patients in
our study were similar to epidemiological studies on the
prevalence of peripheral occlusive arterial disease [19].
Mean rSO2 baseline values did not differ from values ob-
tained from healthy volunteers probably because most
patients had peripheral arterial disease without ischemic
symptoms during rest (Fontaine grade II) [21].
Sevoflurane muscle tissue preconditioning
Sevoflurane protects cardiac tissue by activation of ATP-
dependent potassium channels and inhibition of mito-
chondrial permeability transition pores (MPTP) [22].
ATP-dependent potassium channels are also expressed in
peripheral arteries, thus enabling preconditioning with
sevoflurane in most tissues [23]. Lucchinetti et al. showed
that sevoflurane (0.5 - 1 vol % end-tidal concentration)
improved postocclusive hyperemic reaction after 15 minutesof forearm ischemia, thus suggesting a preconditioning
effect on limb tissue [23]. Two periods of five minutes
of sevoflurane administration (1 MAC) followed by
five minutes of washout have been used for effective
clinical sevoflurane preconditioning [16,21]. Low suba-
nesthetic sedative concentrations of sevoflurane (<1%)
have been shown to be sufficient for pharmacologic
preconditioning [24].
In our study, no significant difference of rSO2 was ob-
served between groups during sevoflurane precondition-
ing. However, rSO2 values tended to be slightly higher in
the sevoflurane group. This is consistent with the known
dilatative effect of sevoflurane on the vascular bed.
Sevoflurane preconditioning had a significant effect on
the time course of rSO2 during IPC. Decrease during the
first clamping interval was less prominent in the sevoflurane
group than in the control group, but more prominent
than in the group with IPC only during the second clamp-
ing interval. Albeit not significantly different from the
control group, rSO2 exceeded baseline values immediately
before clamping in the sevoflurane group only. Hence,
sevoflurane preconditioning may have dilated collateral
vessels of the femoral artery to an extend that rendered a
further preconditioning effect by IPC impossible.
There was no difference of rSO2 between groups dur-
ing surgery, but there was a significant effect of sevo-
flurane on the time course of postoperative reperfusion
with higher rSO2 in the sevoflurane group at the end of
reperfusion.
Taken together, these results suggest successful sevo-
flurane preconditioning of the skeletal muscle.
Ischemic preconditioning
Ischemic preconditioning (IPC) has been described in
numerous clinical and experimental studies [2]. A study
aimed at the efficacy of different preconditioning proto-
cols showed that the efficacy of IPC is probably more
dependent on the number of ischemic periodes and
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periods of 2.5, 5 or 10 minutes resulted in improved
postischemic muscle function [25]. Clamping during IPC
and clamping for surgery led to significant changes of
rSO2 consistent with cyclic ischemia. In the group with-
out sevoflurane preconditioning, rSO2 decreased during
the first clamping period and increased during the first re-
perfusion period. Decrease was less prominent during the
second ischemic period, as exspected after successful is-
chemic preconditioning by the first cycle. Hence, probably
IPC had an effect on leg muscle tissue perfusion in our pa-
tients. These findings are consistent with previous experi-
mental results showing effective IPC of skeletal muscle.
IPC could attenuate capillary flow deficit after ischemia
and reperfusion in isolated dog gracilis muscle [26]. More-
over, it has been shown that IPC can reduce infarct size by
more than 50% in porcine latissimus dorsi flaps and ca-
nine gracilis muscle after ischemia (five hours) and reper-
fusion (72 and 48 hours respectively) [27,28].
Interestingly, IPC caused significant effects with respect
to rSO2 in only 22 out of 40 patients. In the remaining pa-
tients, collaterals may have prevented complete cessation
of blood flow to the lower limb. This points to the fact
that an effective IPC may be only achieved in 50% of pa-
tients undergoing surgery and thus may render sevoflur-
ane preconditioning an interesting alternative.
Remote preconditioning could also have been applied
at sites different from the site of surgery by intermit-
tently inflating a cuff around an extremity. However,
preconditioning performed by inflating a cuff around an
extremity above systolic blood pressure involves risks
like embolism or tissue damage by compression that are
probably more predominant in patients with vascular
disease. Since in most patients vascular disease is not
confined to the extremity at which surgery is performed,
the same risks may occur at the other extremities.
Hence, we prefered to investigate IPC by clamping the
femoral artery with the same clamping technique as ap-
plied for definite clamping for surgery [3].
Heart rate and mean arterial pressure during
preconditioning and reperfusion
There was no difference of mean heart rate between the
sevoflurane group and controls during the measurement
and there was no difference of mean arterial pressure
between the sevoflurane group and controls during is-
chemic preconditioning, surgery and reperfusion. There
was a small difference of mean arterial pressure between
the sevoflurane group and controls during the first
wash-in. This difference was probably caused by the
vasodilatative effect of sevoflurane. The difference was
compensated by the intravenous application of cafedrin-
theodrenalin (Akrinor®) during the following phases of
wash-in and wash-out. This lower mean arterial pressureduring the first sevoflurane wash-in could have contrib-
uted to preconditioning of the leg tissue in principle.
However, the difference was small and was observed
during the first wash-in only. As described above, opti-
mal preconditioning is achieved by cyclic precondition-
ing stimuli. Hence, a substantial preconditioning effect
due to this difference seems unlikely and the precondi-
tioning effect is regarded as caused by sevoflurane only.
Limitations
Measurement of rSO2 by NIRS is influenced by changes
of serum hemoglobine concentration [29]. Serum hemo-
globine decreased during surgery by 2.6 g.dl−1 without
any difference between our study groups. Hence, serum
hemoglobine could have biased our results, but to the
same extent in both groups, thus having no impact on
the differences observed. An influence of pCO2 on rSO2
during the measurement was excluded by continuously
monitoring endtidal pCO2 and keeping it constant [30].
Excessive obesity may also distort measurement of
muscle tissue oxygenation by thick subcutaneous fat
layers, but was not present in our patients [13].
Clinical endpoints were not included in this study, since
the patient number was too small to expect significant dif-
ferences between groups. However, length of hospital stay,
major cardiac events and length of follow up period have
been obtained from the patients charts. There were no sig-
nificant differences between the groups regarding these pa-
rameters. Due to the large variability of occlusive arterial
disease and outcome after surgical revascularization, pos-
sibly a substantially higher patient number is needed to
measure an effect of preconditioning on clinical endpoints.
Conclusion
Ischemic preconditioning by clamping of the femoral artery
and sevoflurane preconditioning of lower limb muscle tis-
sue during surgical revascularization have significant effects
on rSO2 in patients with occlusive arterial disease of the
lower limb. The results suggest that a large scale prospect-
ive randomized trial including an IPC group, a group with
sevoflurane preconditioning and a control group on the ef-
fect of IPC and sevoflurane preconditioning on outcome
after surgical repair of peripheral vascular disease with
major morbidity as clinical endpoint should be performed.
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